Table 2.
Medication administered to the patients before and during/after delta 9-THC therapy. A substantial reduction of the medication within each group, that is, nonopioids, opioids, or nonanalgesics (primarily antidepressants and anticonvulsants), could be recorded during the treatment with delta 9-THC.
| Before delta 9-THC therapy | During/after delta 9-THC therapy | ||||
|---|---|---|---|---|---|
| Comedication | Number of patients | % | Number of patients | % | |
| Nonopioids | NSAID | 60 | 48 | 7 | 5.6 |
| COX2-inhibitors | 34 | 27 | 7 | 5.6 | |
| Paracetamol | 29 | 23 | 3 | 2.4 | |
| Metamizole | 44 | 35 | 10 | 8.1 | |
| Flupirtin | 37 | 30 | 7 | 5.6 | |
| others | 14 | 11 | 2 | 1.6 | |
|
| |||||
| Opioids | Tramadol | 35 | 28 | 2 | 1.6 |
| Naloxone | 36 | 29 | 5 | 4 | |
| Buprenorphin/fentanyl | 15 | 12 | 5 | 4 | |
| Morphin | 22 | 18 | 7 | 5.6 | |
| Hydromorphone | 17 | 14 | 10 | 8.1 | |
| Oxycodone | 13 | 10 | 5 | 4 | |
| Others | 6 | 5 | 5 | 4 | |
|
| |||||
| Nonanalgesics | Antidepressants | 68 | 55 | 18 | 14.5 |
| Anticonvulsants | 40 | 32 | 18 | 14.5 | |
| Corticosteroids | 19 | 15 | 6 | 4.8 | |
| NMDA-antagonists | 5 | 4 | 5 | 4 | |
| Others | 21 | 17 | 7 | 5.6 | |